Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N D James

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Medical Physics|February 9, 1999
Toward a final design for the Birmingham boron neutron capture therapy neutron beamD A Allen, T D Beynon, S Green, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 27, 2010
Recent advances and future directions in the management of metastatic renal cell carcinomaJ Ansari, J Glaholm, R McMenemin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 17, 2008
The management of interruptions to radiotherapy in head and neck cancer: an audit of the effectiveness of national guidelinesN D James, M V Williams, E T Summers, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2006
National survey of radiotherapy fractionation practice in 2003M V Williams, N D James, E T Summers, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2003
A national audit of radiotherapy in head and neck cancerN D James, G Robertson, C J Squire, et al.
The Journal of Pathology|July 9, 1999
CD40 expression in bladder cancerP W Cooke, N D James, R Ganesan, et al.
British Journal of Cancer|July 20, 2001
A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+ advanced prostate cancerN D James, P J Atherton, J Jones, et al.
European Urology|August 15, 2000
Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancerP W Cooke, J A Dunn, T Latief, et al.
BJU International|May 3, 2000
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapyP W Cooke, N D James, R Ganesan, et al.
The Journal of Urology|March 15, 2014
Re: defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition. D. Lamm, R. Persad, M. Brausi, R. Buckley, J. A. Witjes, J. Palou, A. Böhle, A. M. Kamat, M. Colombel and M. Soloway J Urol 2014;191:20-27R T Bryan, K K Cheng, N D James, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Medical Physics|February 9, 1999
Toward a final design for the Birmingham boron neutron capture therapy neutron beamD A Allen, T D Beynon, S Green, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 27, 2010
Recent advances and future directions in the management of metastatic renal cell carcinomaJ Ansari, J Glaholm, R McMenemin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 17, 2008
The management of interruptions to radiotherapy in head and neck cancer: an audit of the effectiveness of national guidelinesN D James, M V Williams, E T Summers, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2006
National survey of radiotherapy fractionation practice in 2003M V Williams, N D James, E T Summers, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2003
A national audit of radiotherapy in head and neck cancerN D James, G Robertson, C J Squire, et al.
The Journal of Pathology|July 9, 1999
CD40 expression in bladder cancerP W Cooke, N D James, R Ganesan, et al.
British Journal of Cancer|July 20, 2001
A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+ advanced prostate cancerN D James, P J Atherton, J Jones, et al.
European Urology|August 15, 2000
Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancerP W Cooke, J A Dunn, T Latief, et al.
BJU International|May 3, 2000
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapyP W Cooke, N D James, R Ganesan, et al.
The Journal of Urology|March 15, 2014
Re: defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition. D. Lamm, R. Persad, M. Brausi, R. Buckley, J. A. Witjes, J. Palou, A. Böhle, A. M. Kamat, M. Colombel and M. Soloway J Urol 2014;191:20-27R T Bryan, K K Cheng, N D James, et al.
Pageof 6